751 contracts in Meridian's agencies, NAICS codes and size range reach the end of their current period within 18 months. Below is what that narrows to once filtered to a 3–12 month research window, open competition, and the signals that make a target worth a closer look.
Bar length is proportional to contract count. Source: USAspending.gov prime award archives. Contravalis analysis.
Why it's here: won with a single bid, and six months is enough runway to build a capture plan without rushing. HRSA-family buyer, in Meridian's core NAICS. Honest gap: this is the only award on record in this exact product/service code — no comparable price or competition history to check it against.
Why it's here: the largest near-term value on the list with only two prior bidders — worth confirming CDC's re-solicitation timeline now, given the shorter runway. Priced at the low end of what 135 comparable HHS/541611 awards in this size band typically go for (25th percentile $7.0M, median $9.1M) — not unusual, but worth knowing before pricing a bid.
Why it's here: two independent signals point the same direction. The ceiling has grown to more than 4x what was originally competed, and the current $4.0M value sits well above the typical range for 409 comparable HHS/541611 awards this size (25th–75th percentile $0.5M–$2.7M). Offer count isn't reported for this award, so competition itself can't be assessed directly — the scope growth and the price outlier are what earn the closer look.
Why it's here: same buyer and window as the Ipsos target above, priced just under the usual range for this cell — worth a look once the higher-priority items are underway.
Why it's here, and why not higher: the largest contract on this list, but the same vendor — Advanced Bioscience Laboratories itself — has won all 3 prior awards on record in this exact NIH/541512 cell. That's a concentrated incumbent, not a thin field: worth investigating why (a technical or certification barrier?) before committing pursuit hours, not treating it as an easy opening. That peer band stands on three comparable awards from a single vendor, which is thin; read it as a range, not a rule.
Source: USAspending.gov prime award archives. Contravalis analysis. Peer price bands are the 25th–75th percentile of comparable awards in the same agency, NAICS and size band. Offer counts are unreported on a meaningful share of federal awards.
| Incumbent | Ends | Value | Offers | Note |
|---|---|---|---|---|
| JBS InternationalHRSA | Dec 2026 · 3 mo | $3.3M | 3 | Short runway, wider field already |
| ICF IncorporatedNIH | Sep 2027 · 12 mo | $5.8M | 1 | Long runway — revisit closer to the window |
| Mathematica Inc.ACF | Sep 2027 · 12 mo | $4.2M | 1 | Long runway — revisit closer to the window |
| MDRCACF | Sep 2027 · 12 mo | $4.5M | 1 | Long runway — revisit closer to the window |
| Guidehouse Inc.CDC | Mar 2027 · 6 mo | $2.7M | 5 | Crowded field — lower priority |
Source: USAspending.gov prime award archives. Contravalis analysis.
This brief filtered 751 possible contracts down to 5 worth researching this week — the pursuit-hours question a capture team actually needs answered, not a longer list. The price bands come from the same live tool: put in any agency, NAICS and PSC and it returns the comparable awards, price range and upcoming recompetes for that cell.
This brief used an illustrative profile. The same ranked list runs against your real agencies, NAICS codes and contract size — with real targets, not a demonstration.
Reply with your top two or three agencies, your NAICS codes and your typical contract size, and I'll build it this week — jonas@contravalis.com